Alli vs Orlos
Start with the difference that matters most, then use the related treatment, provider or specialist pages for the next check.
Use this comparison well
The practical differences between the routes, including access, treatment type, cost context and what to compare before choosing.
It does not decide clinical suitability, supply, dose, stock, prescribing outcome or final checkout price.
Use the comparison links below to move into Mounjaro, Wegovy, tablets or broader provider comparison.
Alli and Orlos are both lower-dose orlistat routes, but they can still be presented differently by provider or pharmacy pages. Compare the route clearly before relying on pack detail, price or guidance alone.
Compare pack detail, guidance and how the treatment is described
The useful comparison is not just the name on the box. It is whether the route, strength, pack size, guidance, provider checks and delivery details are clear enough to compare properly.
Alli
Check how the treatment is described, the pack size, provider checks and the practical guidance.
Orlos
Check how clearly the route is described and whether the practical detail is easy to compare.
Provider detail
Price, delivery, pharmacist involvement and guidance can differ even when the route looks similar.
Next comparison step
Choose the next comparison to open
Use these routes when the current page gives you context but you need a more specific provider, treatment or tablet comparison next.
For users who already know they want a Mounjaro-focused provider comparison with dose, support and provider details.
WegovyCompare Wegovy providersFor users comparing Wegovy provider fit, delivery, support, offer context and current price ranges.
TabletsCheck tablet and oral routesFor users trying to understand tablets, capsules, oral semaglutide, Rybelsus and what is actually available in the UK.
ProvidersCompare broader providersFor users who still need a wider clinic/provider view across treatment types, delivery, support and trust context.
Information only. These links help you compare options; a regulated provider decides suitability, stock, terms and final payable amount.
Comparison next step
Turn the comparison into a provider and treatment decision
Comparison pages work best when they move people into the clinic shortlist, the provider pages and the treatment pages that explain how the choice changes by route.
Source checks
Xenical Prescribing Information
The Xenical Summary of Product Characteristics was reviewed only for wider orlistat-family context.
Checked: 27 April 2026 Confidence: High
Source: eMC: Xenical 120 mg hard capsules SmPC
Used cautiously as related family context where official lower-dose route information is limited in the source-check table.
Alli Prescribing Information
The alli Summary of Product Characteristics was reviewed for medicine identity and background.
Checked: 27 April 2026 Confidence: High
Source: eMC: alli 60 mg hard capsules SmPC
Used to support explanation of the Alli route within the orlistat family.
NHS Orlistat Context
NHS medicines information was reviewed for orlistat background.
Checked: 27 April 2026 Confidence: High
Source: NHS medicines: Orlistat
Reviewed for broad public explanation of the orlistat capsule route and suitability checks.
Important information
This website is an informational comparison hub. It does not prescribe, supply or sell prescription-only medicines. Suitability depends on a regulated clinical assessment.
Some links may be affiliate or commercial links. Commercial relationships must not change the way safety, eligibility, source checks or editorial context are presented.